Skip to content
DataLookout
Start free
Menu

STANDARDIZE-PVNCT07734272

Standardized Documentation and Assessments for Polycythemia Vera: A Quality Improvement Initiative

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 4 more changesShow less
    • Eligibility criteria expanded, about 2 words
    • Study sites: 0 to 1
    • Start date changed from estimate of Aug 5, 2026 to Sep 11, 2026
    • Secondary endpoints: details revised at 2 of 2 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Feasibility of intervention
Timeframe: 12 months

Secondary (2)

Acceptibility of intervention
Appropriateness of intervention

Arms and interventions

Standardized note with standard-of-care pharmacist supportExperimental

Standardized progress note templates with opt-in option for standard-of-care pharmacist support of ropeginterferon alfa-2b titration

Behavioral: Standardized progress note

Sites

1 site in 1 country

  • Mass General Brigham Cancer InstituteBoston, Massachusetts, United States